By Benjamin Chiou
Date: Monday 13 Oct 2025
(Sharecast News) - IP Group said it is "encouraged" by the results of a recent clinical trial of a Metsara obesity drug, which could result in future sustainable royalties if approved by regulators.
By Michele Maatouk
Date: Wednesday 01 Oct 2025
(Sharecast News) - US President Donald Trump's 'Most Favoured Nation' deal with Pfizer could be a bellwether for the pharmaceutical sector and reassure investors over a broadly manageable impact, JPMorgan said in a research note
By Abigail Townsend
Date: Monday 22 Sep 2025
(Sharecast News) - Pfizer Inc has agreed to buy biotech Metsera in multi-billion dollar deal, the US drugs giant confirmed on Monday, giving it a foothold in the booming weight-loss sector and sending shares in the start-up soaring.
Currency | US Dollars |
Share Price | $ 24.51 |
Change Today | $ 0.28 |
% Change | 1.16 % |
52 Week High | $29.27 |
52 Week Low | $21.59 |
Volume | 40,101,861 |
Shares Issued | 5,667m |
Market Cap | $138,898m |
Beta | 0.45 |
RiskGrade | 102 |
Strong Buy | 4 |
Buy | 5 |
Neutral | 14 |
Sell | 0 |
Strong Sell | 1 |
Total | 24 |
Time | Volume / Share Price |
16:00 | 2,613,428 @ $24.51 |
15:59 | 1,400 @ $24.52 |
15:59 | 154 @ $24.52 |
15:59 | 344 @ $24.52 |
15:59 | 115 @ $24.51 |
You are here: research